Turning wild-type lysins into drug-grade ε²Lysins
What makes PhagoMed’s ε²Lysins special?
-
In-silico discovery based on proprietary algorithms
-
Directed recombination of natural lysins using the ε² Platform
-
Optimized for potency, stability and manufacturing yield
-
Highly bactericidal & highly precise
-
Broad patent protection secured
Natural endolysins recombined to create endolysin with superior phenotype
Natural lysin 1
Natural lysin 2
ε²Lysin
Recombinations